Clearline Capital LP Bausch & Lomb Corp Transaction History
Clearline Capital LP
- $2.27 Billion
- Q3 2024
A detailed history of Clearline Capital LP transactions in Bausch & Lomb Corp stock. As of the latest transaction made, Clearline Capital LP holds 710,055 shares of BLCO stock, worth $12.8 Million. This represents 0.6% of its overall portfolio holdings.
Number of Shares
710,055
Previous 712,055
0.28%
Holding current value
$12.8 Million
Previous $10.3 Million
32.47%
% of portfolio
0.6%
Previous 0.3%
Shares
8 transactions
Others Institutions Holding BLCO
# of Institutions
118Shares Held
37.8MCall Options Held
116KPut Options Held
299K-
Maple Rock Capital Partners Inc. Toronto, A63.62MShares$65.1 Million2.04% of portfolio
-
Icahn Carl C Sunny Isles Beach, FL3.5MShares$63 Million0.69% of portfolio
-
Goldentree Asset Management LP New York, NY3.36MShares$60.4 Million5.89% of portfolio
-
Alberta Investment Management Corp Edmonton, A02.21MShares$39.8 Million0.42% of portfolio
-
River Road Asset Management, LLC2.02MShares$36.3 Million0.54% of portfolio
About Bausch & Lomb Corp
- Ticker BLCO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 350,000,000
- Market Cap $6.3B
- Description
- Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...